| Product Code: ETC7644887 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Angina Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Angina Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Angina Market - Industry Life Cycle |
3.4 Israel Angina Market - Porter's Five Forces |
3.5 Israel Angina Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Angina Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Israel Angina Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Angina Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lifestyle-related risk factors such as obesity and diabetes |
4.2.2 Advancements in medical technology for diagnosis and treatment of angina |
4.2.3 Growing awareness about cardiovascular health and preventive measures |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for new drug approvals |
4.3.2 High cost associated with innovative treatments and procedures |
4.3.3 Limited access to healthcare services in certain regions of Israel |
5 Israel Angina Market Trends |
6 Israel Angina Market, By Types |
6.1 Israel Angina Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Angina Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Angina Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.1.4 Israel Angina Market Revenues & Volume, By Nitrates and Calcium Channel Blockers, 2021- 2031F |
6.1.5 Israel Angina Market Revenues & Volume, By Angiotensin-Converting Enzyme Inhibitors, 2021- 2031F |
6.1.6 Israel Angina Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Angina Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Israel Angina Market Revenues & Volume, By Stable Angina and Unstable Angina, 2021- 2031F |
6.2.3 Israel Angina Market Revenues & Volume, By Variant (Prinzmetal) Angina, 2021- 2031F |
6.2.4 Israel Angina Market Revenues & Volume, By Microvascular Angina, 2021- 2031F |
6.3 Israel Angina Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Angina Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Israel Angina Market Revenues & Volume, By Cardiology Centers, 2021- 2031F |
6.3.4 Israel Angina Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Angina Market Import-Export Trade Statistics |
7.1 Israel Angina Market Export to Major Countries |
7.2 Israel Angina Market Imports from Major Countries |
8 Israel Angina Market Key Performance Indicators |
8.1 Number of patients undergoing cardiac screenings for angina |
8.2 Adoption rate of minimally invasive procedures for angina treatment |
8.3 Investment in research and development for angina therapies |
8.4 Rate of hospital readmissions for angina-related complications |
8.5 Patient satisfaction with angina management services |
9 Israel Angina Market - Opportunity Assessment |
9.1 Israel Angina Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Angina Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Israel Angina Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Angina Market - Competitive Landscape |
10.1 Israel Angina Market Revenue Share, By Companies, 2024 |
10.2 Israel Angina Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here